Abstract
There exists a lot of diversity in Indian pharmaceutical environment in various aspects. We have applied Delphi Technique to arrive at specific prevalent diseases in India and identified 24 pharmaceutical firms making drugs for these diseases. We used data envelopment analysis (DEA) approach to find out the efficiency of firms and peers of inefficient firms. Tobit regression has been used to get the determinants of efficiency.
Highlights
India is rapidly growing to become a major and vibrant economic power, in spite of the wide disparities within its social milieu
The pharmaceutical market has witnessed a strong double – digit growth ranging from 13.5 % to 17 % over the past four years
Considering the above stated Pareto’s approach we have considered 24 pharmaceutical firms which contribute to more than 80 % of the business
Summary
India is rapidly growing to become a major and vibrant economic power, in spite of the wide disparities within its social milieu. Multi National Companies (MNCs) are attracted by the emerging markets in Indian scenario for generic drugs. Sampath (2005) provided studies on “Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry”. Delphi technique used to form consensus after opinions from experts for specific prevalent diseases in Indian context. Study on these firms was arrived based on drugs (generic names) and older (Innovator) drugs, specific against the diseases, available in market. The panelists have at each stage a full record of what comments and nominations other panelists have made, but they do not know who made which comment or voted for which entry Nor do they know the final result, till the same was disclosed after the consensus which was reached after 3 rounds for the widely prevalent diseases in Indian context fit for the studies. Formed Karnataka Antibiotic ltd (KAPL) NPIL Biddle Sawyer Torrent Dabur Hygeia Khandelwal Indswift Taurus Balpharma Wyeth Laderly FDC
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: INTERNATIONAL JOURNAL OF MANAGEMENT & INFORMATION TECHNOLOGY
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
